Six out of 31 total new small molecules approved by the FDA in 2024 were produced by Wuxi, said the company's co-CEO.
In 2024, drug makers lowered the cost of dozens of common medications to avoid penalties imposed by the American Rescue Plan, Katie Thomas of ...
Berenberg analyst Kerry Holford lowered the firm’s price target on Eli Lilly (LLY) to $970 from $1,050 and keeps a Buy rating on the shares.
Taiwan Semiconductor Manufacturing reported a 57% rise in profit on strong demand for hardware to power AI systems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback